Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,847 | 355 | 99.6% |
| Education | $31.24 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $700.76 | 26 | $0 (2024) |
| Amgen Inc. | $638.40 | 17 | $0 (2019) |
| Novo Nordisk Inc | $624.74 | 41 | $0 (2024) |
| ABBVIE INC. | $575.75 | 24 | $0 (2024) |
| Lilly USA, LLC | $536.14 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $529.10 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $442.96 | 21 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $374.97 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $361.04 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $265.41 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $971.35 | 31 | Phathom Pharmaceuticals, Inc. ($374.97) |
| 2023 | $629.28 | 14 | E.R. Squibb & Sons, L.L.C. ($165.13) |
| 2022 | $685.58 | 7 | Lilly USA, LLC ($250.00) |
| 2021 | $260.19 | 4 | AstraZeneca Pharmaceuticals LP ($121.70) |
| 2020 | $360.27 | 13 | Esperion Therapeutics, Inc. ($115.96) |
| 2019 | $1,172 | 74 | Janssen Pharmaceuticals, Inc ($181.17) |
| 2018 | $1,719 | 93 | AbbVie, Inc. ($346.30) |
| 2017 | $2,080 | 121 | Amgen Inc. ($350.28) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardio-renal | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes Care | ||||||
| 07/20/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $99.10 | General |
| Category: Neuroscience | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Endocrinology | ||||||
| 05/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,149 | 1,750 | $192,617 | $97,307 |
| 2022 | 11 | 1,447 | 2,057 | $218,548 | $117,539 |
| 2021 | 9 | 1,363 | 2,196 | $213,911 | $154,358 |
| 2020 | 9 | 1,511 | 2,426 | $207,866 | $137,420 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 747 | $77,525 | $36,904 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 375 | $55,205 | $26,375 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 255 | 255 | $35,902 | $18,300 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 76 | 76 | $7,510 | $4,427 | 58.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 128 | 128 | $4,150 | $3,758 | 90.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 66 | 66 | $2,310 | $2,094 | 90.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $3,800 | $2,081 | 54.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $3,580 | $1,577 | 44.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 64 | 64 | $1,600 | $1,309 | 81.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 13 | $1,035 | $482.52 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 331 | 721 | $70,995 | $35,812 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 262 | 476 | $65,410 | $31,585 | 48.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 323 | 323 | $46,068 | $26,438 | 57.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 141 | 141 | $14,100 | $9,267 | 65.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 157 | 157 | $3,880 | $3,696 | 95.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $2,480 | $2,320 | 93.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 74 | 74 | $2,590 | $2,216 | 85.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 17 | $4,305 | $1,646 | 38.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 82 | 82 | $2,050 | $1,646 | 80.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 35 | 38 | $3,070 | $1,510 | 49.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $3,600 | $1,403 | 39.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 391 | 1,085 | $103,075 | $66,391 | 64.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 342 | 342 | $48,566 | $44,559 | 91.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 328 | $42,940 | $29,794 | 69.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 185 | 185 | $4,650 | $2,995 | 64.4% |
About Dr. Boris Gliner, M.D
Dr. Boris Gliner, M.D is a Internal Medicine healthcare provider based in Parma, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982648507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boris Gliner, M.D has received a total of $7,878 in payments from pharmaceutical and medical device companies, with $971.35 received in 2024. These payments were reported across 357 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,847).
As a Medicare-enrolled provider, Gliner has provided services to 5,470 Medicare beneficiaries, totaling 8,429 services with total Medicare billing of $506,625. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist
- Location Parma, OH
- Active Since 06/15/2006
- Last Updated 09/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982648507
Products in Payments
- ELIQUIS (Drug) $650.26
- JARDIANCE (Drug) $520.52
- VOQUEZNA (Drug) $374.97
- NURTEC ODT (Drug) $338.34
- XARELTO (Drug) $327.72
- Creon (Drug) $262.33
- Prolia (Biological) $249.54
- ENTRESTO (Drug) $228.06
- Victoza (Drug) $212.40
- Repatha (Biological) $209.74
- Ozempic (Drug) $185.28
- AJOVY (Drug) $169.48
- Livalo (Drug) $153.08
- FARXIGA (Drug) $152.86
- CHANTIX (Drug) $152.71
- Aimovig (Biological) $148.83
- BREZTRI (Drug) $135.02
- SHINGRIX (Biological) $133.74
- MOUNJARO (Drug) $125.00
- GVOKE HYPOPEN (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parma
Dr. Charles Koepke, Md, MD
Internal Medicine — Payments: $10,439
Jason Ice, Do, DO
Internal Medicine — Payments: $10,215
Florin Penciu, Md, MD
Internal Medicine — Payments: $9,339
Dr. Morgan Koepke, Md, MD
Internal Medicine — Payments: $7,488
Amir Naraghi, Md, MD
Internal Medicine — Payments: $4,620
Samson Ballesteros, M.d, M.D
Internal Medicine — Payments: $2,354